Global Biologics and Biosimilars Market Research Report 2023

Global Biologics and Biosimilars Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics and Biosimilars Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Insulin
1.2.5 Vaccines
1.2.6 Others
1.3 Market by Application
1.3.1 Global Biologics and Biosimilars Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics and Biosimilars Market Perspective (2018-2029)
2.2 Biologics and Biosimilars Growth Trends by Region
2.2.1 Global Biologics and Biosimilars Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biologics and Biosimilars Historic Market Size by Region (2018-2023)
2.2.3 Biologics and Biosimilars Forecasted Market Size by Region (2024-2029)
2.3 Biologics and Biosimilars Market Dynamics
2.3.1 Biologics and Biosimilars Industry Trends
2.3.2 Biologics and Biosimilars Market Drivers
2.3.3 Biologics and Biosimilars Market Challenges
2.3.4 Biologics and Biosimilars Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics and Biosimilars Players by Revenue
3.1.1 Global Top Biologics and Biosimilars Players by Revenue (2018-2023)
3.1.2 Global Biologics and Biosimilars Revenue Market Share by Players (2018-2023)
3.2 Global Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologics and Biosimilars Revenue
3.4 Global Biologics and Biosimilars Market Concentration Ratio
3.4.1 Global Biologics and Biosimilars Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics and Biosimilars Revenue in 2022
3.5 Biologics and Biosimilars Key Players Head office and Area Served
3.6 Key Players Biologics and Biosimilars Product Solution and Service
3.7 Date of Enter into Biologics and Biosimilars Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics and Biosimilars Breakdown Data by Type
4.1 Global Biologics and Biosimilars Historic Market Size by Type (2018-2023)
4.2 Global Biologics and Biosimilars Forecasted Market Size by Type (2024-2029)
5 Biologics and Biosimilars Breakdown Data by Application
5.1 Global Biologics and Biosimilars Historic Market Size by Application (2018-2023)
5.2 Global Biologics and Biosimilars Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Biologics and Biosimilars Market Size (2018-2029)
6.2 North America Biologics and Biosimilars Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Biologics and Biosimilars Market Size by Country (2018-2023)
6.4 North America Biologics and Biosimilars Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics and Biosimilars Market Size (2018-2029)
7.2 Europe Biologics and Biosimilars Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Biologics and Biosimilars Market Size by Country (2018-2023)
7.4 Europe Biologics and Biosimilars Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics and Biosimilars Market Size (2018-2029)
8.2 Asia-Pacific Biologics and Biosimilars Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Biologics and Biosimilars Market Size by Region (2018-2023)
8.4 Asia-Pacific Biologics and Biosimilars Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics and Biosimilars Market Size (2018-2029)
9.2 Latin America Biologics and Biosimilars Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Biologics and Biosimilars Market Size by Country (2018-2023)
9.4 Latin America Biologics and Biosimilars Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics and Biosimilars Market Size (2018-2029)
10.2 Middle East & Africa Biologics and Biosimilars Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Biologics and Biosimilars Market Size by Country (2018-2023)
10.4 Middle East & Africa Biologics and Biosimilars Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Biologics and Biosimilars Introduction
11.1.4 Roche Revenue in Biologics and Biosimilars Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Biologics and Biosimilars Introduction
11.2.4 Amgen Revenue in Biologics and Biosimilars Business (2018-2023)
11.2.5 Amgen Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Biologics and Biosimilars Introduction
11.3.4 AbbVie Revenue in Biologics and Biosimilars Business (2018-2023)
11.3.5 AbbVie Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Biologics and Biosimilars Introduction
11.4.4 Sanofi Revenue in Biologics and Biosimilars Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Biologics and Biosimilars Introduction
11.5.4 Johnson & Johnson Revenue in Biologics and Biosimilars Business (2018-2023)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Biologics and Biosimilars Introduction
11.6.4 Pfizer Revenue in Biologics and Biosimilars Business (2018-2023)
11.6.5 Pfizer Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Detail
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Biologics and Biosimilars Introduction
11.7.4 Novo Nordisk Revenue in Biologics and Biosimilars Business (2018-2023)
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Detail
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Biologics and Biosimilars Introduction
11.8.4 Eli Lilly Revenue in Biologics and Biosimilars Business (2018-2023)
11.8.5 Eli Lilly Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Biologics and Biosimilars Introduction
11.9.4 Novartis Revenue in Biologics and Biosimilars Business (2018-2023)
11.9.5 Novartis Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Biologics and Biosimilars Introduction
11.10.4 Merck Revenue in Biologics and Biosimilars Business (2018-2023)
11.10.5 Merck Recent Development
11.11 Biogen
11.11.1 Biogen Company Detail
11.11.2 Biogen Business Overview
11.11.3 Biogen Biologics and Biosimilars Introduction
11.11.4 Biogen Revenue in Biologics and Biosimilars Business (2018-2023)
11.11.5 Biogen Recent Development
11.12 Celltrion
11.12.1 Celltrion Company Detail
11.12.2 Celltrion Business Overview
11.12.3 Celltrion Biologics and Biosimilars Introduction
11.12.4 Celltrion Revenue in Biologics and Biosimilars Business (2018-2023)
11.12.5 Celltrion Recent Development
11.13 Sobi
11.13.1 Sobi Company Detail
11.13.2 Sobi Business Overview
11.13.3 Sobi Biologics and Biosimilars Introduction
11.13.4 Sobi Revenue in Biologics and Biosimilars Business (2018-2023)
11.13.5 Sobi Recent Development
11.14 3SBIO
11.14.1 3SBIO Company Detail
11.14.2 3SBIO Business Overview
11.14.3 3SBIO Biologics and Biosimilars Introduction
11.14.4 3SBIO Revenue in Biologics and Biosimilars Business (2018-2023)
11.14.5 3SBIO Recent Development
11.15 Changchun High Tech
11.15.1 Changchun High Tech Company Detail
11.15.2 Changchun High Tech Business Overview
11.15.3 Changchun High Tech Biologics and Biosimilars Introduction
11.15.4 Changchun High Tech Revenue in Biologics and Biosimilars Business (2018-2023)
11.15.5 Changchun High Tech Recent Development
11.16 Kanghong Pharma
11.16.1 Kanghong Pharma Company Detail
11.16.2 Kanghong Pharma Business Overview
11.16.3 Kanghong Pharma Biologics and Biosimilars Introduction
11.16.4 Kanghong Pharma Revenue in Biologics and Biosimilars Business (2018-2023)
11.16.5 Kanghong Pharma Recent Development
11.17 Innovent Biologics
11.17.1 Innovent Biologics Company Detail
11.17.2 Innovent Biologics Business Overview
11.17.3 Innovent Biologics Biologics and Biosimilars Introduction
11.17.4 Innovent Biologics Revenue in Biologics and Biosimilars Business (2018-2023)
11.17.5 Innovent Biologics Recent Development
11.18 Gan&Lee
11.18.1 Gan&Lee Company Detail
11.18.2 Gan&Lee Business Overview
11.18.3 Gan&Lee Biologics and Biosimilars Introduction
11.18.4 Gan&Lee Revenue in Biologics and Biosimilars Business (2018-2023)
11.18.5 Gan&Lee Recent Development
11.19 Tonghua Dongbao
11.19.1 Tonghua Dongbao Company Detail
11.19.2 Tonghua Dongbao Business Overview
11.19.3 Tonghua Dongbao Biologics and Biosimilars Introduction
11.19.4 Tonghua Dongbao Revenue in Biologics and Biosimilars Business (2018-2023)
11.19.5 Tonghua Dongbao Recent Development
11.20 United Laboratory
11.20.1 United Laboratory Company Detail
11.20.2 United Laboratory Business Overview
11.20.3 United Laboratory Biologics and Biosimilars Introduction
11.20.4 United Laboratory Revenue in Biologics and Biosimilars Business (2018-2023)
11.20.5 United Laboratory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Biologics and Biosimilars Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Interferon
Table 4. Key Players of Insulin
Table 5. Key Players of Vaccines
Table 6. Key Players of Others
Table 7. Global Biologics and Biosimilars Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Biologics and Biosimilars Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Biologics and Biosimilars Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Biologics and Biosimilars Market Share by Region (2018-2023)
Table 11. Global Biologics and Biosimilars Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Biologics and Biosimilars Market Share by Region (2024-2029)
Table 13. Biologics and Biosimilars Market Trends
Table 14. Biologics and Biosimilars Market Drivers
Table 15. Biologics and Biosimilars Market Challenges
Table 16. Biologics and Biosimilars Market Restraints
Table 17. Global Biologics and Biosimilars Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Biologics and Biosimilars Market Share by Players (2018-2023)
Table 19. Global Top Biologics and Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics and Biosimilars as of 2022)
Table 20. Ranking of Global Top Biologics and Biosimilars Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Biologics and Biosimilars Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Biologics and Biosimilars Product Solution and Service
Table 24. Date of Enter into Biologics and Biosimilars Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biologics and Biosimilars Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Biologics and Biosimilars Revenue Market Share by Type (2018-2023)
Table 28. Global Biologics and Biosimilars Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Biologics and Biosimilars Revenue Market Share by Type (2024-2029)
Table 30. Global Biologics and Biosimilars Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Biologics and Biosimilars Revenue Market Share by Application (2018-2023)
Table 32. Global Biologics and Biosimilars Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Biologics and Biosimilars Revenue Market Share by Application (2024-2029)
Table 34. North America Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Biologics and Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Biologics and Biosimilars Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Biologics and Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Biologics and Biosimilars Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Biologics and Biosimilars Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Biologics and Biosimilars Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Biologics and Biosimilars Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Biologics and Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Biologics and Biosimilars Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Biologics and Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Biologics and Biosimilars Market Size by Country (2024-2029) & (US$ Million)
Table 49. Roche Company Detail
Table 50. Roche Business Overview
Table 51. Roche Biologics and Biosimilars Product
Table 52. Roche Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 53. Roche Recent Development
Table 54. Amgen Company Detail
Table 55. Amgen Business Overview
Table 56. Amgen Biologics and Biosimilars Product
Table 57. Amgen Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 58. Amgen Recent Development
Table 59. AbbVie Company Detail
Table 60. AbbVie Business Overview
Table 61. AbbVie Biologics and Biosimilars Product
Table 62. AbbVie Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 63. AbbVie Recent Development
Table 64. Sanofi Company Detail
Table 65. Sanofi Business Overview
Table 66. Sanofi Biologics and Biosimilars Product
Table 67. Sanofi Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. Johnson & Johnson Company Detail
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Biologics and Biosimilars Product
Table 72. Johnson & Johnson Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. Pfizer Company Detail
Table 75. Pfizer Business Overview
Table 76. Pfizer Biologics and Biosimilars Product
Table 77. Pfizer Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 78. Pfizer Recent Development
Table 79. Novo Nordisk Company Detail
Table 80. Novo Nordisk Business Overview
Table 81. Novo Nordisk Biologics and Biosimilars Product
Table 82. Novo Nordisk Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 83. Novo Nordisk Recent Development
Table 84. Eli Lilly Company Detail
Table 85. Eli Lilly Business Overview
Table 86. Eli Lilly Biologics and Biosimilars Product
Table 87. Eli Lilly Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 88. Eli Lilly Recent Development
Table 89. Novartis Company Detail
Table 90. Novartis Business Overview
Table 91. Novartis Biologics and Biosimilars Product
Table 92. Novartis Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Merck Company Detail
Table 95. Merck Business Overview
Table 96. Merck Biologics and Biosimilars Product
Table 97. Merck Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 98. Merck Recent Development
Table 99. Biogen Company Detail
Table 100. Biogen Business Overview
Table 101. Biogen Biologics and Biosimilars Product
Table 102. Biogen Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 103. Biogen Recent Development
Table 104. Celltrion Company Detail
Table 105. Celltrion Business Overview
Table 106. Celltrion Biologics and Biosimilars Product
Table 107. Celltrion Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 108. Celltrion Recent Development
Table 109. Sobi Company Detail
Table 110. Sobi Business Overview
Table 111. Sobi Biologics and Biosimilars Product
Table 112. Sobi Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 113. Sobi Recent Development
Table 114. 3SBIO Company Detail
Table 115. 3SBIO Business Overview
Table 116. 3SBIO Biologics and Biosimilars Product
Table 117. 3SBIO Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 118. 3SBIO Recent Development
Table 119. Changchun High Tech Company Detail
Table 120. Changchun High Tech Business Overview
Table 121. Changchun High Tech Biologics and Biosimilars Product
Table 122. Changchun High Tech Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 123. Changchun High Tech Recent Development
Table 124. Kanghong Pharma Company Detail
Table 125. Kanghong Pharma Business Overview
Table 126. Kanghong Pharma Biologics and Biosimilars Product
Table 127. Kanghong Pharma Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 128. Kanghong Pharma Recent Development
Table 129. Innovent Biologics Company Detail
Table 130. Innovent Biologics Business Overview
Table 131. Innovent Biologics Biologics and Biosimilars Product
Table 132. Innovent Biologics Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 133. Innovent Biologics Recent Development
Table 134. Gan&Lee Company Detail
Table 135. Gan&Lee Business Overview
Table 136. Gan&Lee Biologics and Biosimilars Product
Table 137. Gan&Lee Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 138. Gan&Lee Recent Development
Table 139. Tonghua Dongbao Company Detail
Table 140. Tonghua Dongbao Business Overview
Table 141. Tonghua Dongbao Biologics and Biosimilars Product
Table 142. Tonghua Dongbao Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 143. Tonghua Dongbao Recent Development
Table 144. United Laboratory Company Detail
Table 145. United Laboratory Business Overview
Table 146. United Laboratory Biologics and Biosimilars Product
Table 147. United Laboratory Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 148. United Laboratory Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologics and Biosimilars Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Biologics and Biosimilars Market Share by Type: 2022 VS 2029
Figure 3. Monoclonal Antibodies Features
Figure 4. Interferon Features
Figure 5. Insulin Features
Figure 6. Vaccines Features
Figure 7. Others Features
Figure 8. Global Biologics and Biosimilars Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Biologics and Biosimilars Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Other Case Studies
Figure 13. Biologics and Biosimilars Report Years Considered
Figure 14. Global Biologics and Biosimilars Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Biologics and Biosimilars Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Biologics and Biosimilars Market Share by Region: 2022 VS 2029
Figure 17. Global Biologics and Biosimilars Market Share by Players in 2022
Figure 18. Global Top Biologics and Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics and Biosimilars as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Biologics and Biosimilars Revenue in 2022
Figure 20. North America Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Biologics and Biosimilars Market Share by Country (2018-2029)
Figure 22. United States Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Biologics and Biosimilars Market Share by Country (2018-2029)
Figure 26. Germany Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Biologics and Biosimilars Market Share by Region (2018-2029)
Figure 34. China Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Biologics and Biosimilars Market Share by Country (2018-2029)
Figure 42. Mexico Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Biologics and Biosimilars Market Share by Country (2018-2029)
Figure 46. Turkey Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 49. Amgen Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 50. AbbVie Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 51. Sanofi Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 52. Johnson & Johnson Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 53. Pfizer Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 54. Novo Nordisk Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 55. Eli Lilly Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 56. Novartis Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 57. Merck Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 58. Biogen Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 59. Celltrion Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 60. Sobi Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 61. 3SBIO Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 62. Changchun High Tech Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 63. Kanghong Pharma Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 64. Innovent Biologics Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 65. Gan&Lee Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 66. Tonghua Dongbao Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 67. United Laboratory Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Insights, Forecast to 2029

Published: 22-Sep-2023        Price: US 4900 Onwards        Pages: 115

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactu......

Global Biologics and Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Sep-2023        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Biologics and Biosimilars market: According to our latest research, the global Biologics and Biosimilars market looks promising in the next 5 years. As of 2022, the global Biologics and Biosimilars market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Biosimilars are biomedical products that are almost identical to the original products made by different companies. ......

Global Biosimilar Drug Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 01-Aug-2023        Price: US 3260 Onwards        Pages: 125

Biosimilar therapy is defined as a therapy that is highly similar to approved biopharmaceuticals. They are made by converting biopharmaceuticals made from living cells in the laboratory into large-scale production molecules. This is quite different from the general treatment method, which is identical to the reference small molecule drug. The reason behind this is that it is impossible to make a copy of the same biologic drug. The Biosimilar Drug market revenue was 16199.84 Million USD in......

Global Oncology Biosimilars Market Insights, Forecast to 2029

Published: 07-Jul-2023        Price: US 4900 Onwards        Pages: 110

Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These molecules are cost-effective, efficient, and have the same ability as biologics. These molecules are easy to manufacture as compared to biologics and can only be manufactured after patent expiry. Earlier there were various patented biologics available in the market but nowadays most of the patents have expired and few are on the verge of patent expiry......

Global Adalimumab Biosimilar Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 04-Jul-2023        Price: US 3260 Onwards        Pages: 125

Adalimumab was a first fully humanized monoclonal antibody approved by US Food and Drug Administration (FDA) in 2002. Clinical efficacy and safety of adalimumab has been assessed in various trials in rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis. It is one of the major sales success among biological and still one of the greatest blockbuster amongst monoclonal antibodies. The Adalimumab Biosimilar market revenue was 2......

Global Follow-On-Biologics Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 22-Jun-2023        Price: US 3260 Onwards        Pages: 114

The Follow-On-Biologics market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Follow-On-Biologics industry, and breaks down according to the type, application, and consumption area of Follow-On-Biologics. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describe......

Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin, Erythropoietin, Anticoagulants. rhGH), Indication, Region - Global Forecast to 2028

Published: 15-Jun-2023        Price: US 4950 Onwards        Pages: 306

“The biosimilars market is projected to grow at a CAGR of 17.8% during the forecast of 2023-2028” The global biosimilars market size is projected to reach USD 66.9 billion by 2028 from USD 29.4 billion in 2023, at a CAGR of 17.8% during the forecast period. Factors such as regulatory approvals, favorable reimbursement policies, rising demand for cost effective biosimilars is driving the market growth. “The monoclonal antibodies produc......

Global Biosimilars-On-Biologics Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 06-Jun-2023        Price: US 3260 Onwards        Pages: 130

The Biosimilars-On-Biologics market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Biosimilars-On-Biologics industry, and breaks down according to the type, application, and consumption area of Biosimilars-On-Biologics. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......

Global Biosimilars Partnering Terms and Agreements 2010 to 2023

Published: 01-Jun-2023        Price: US 3995 Onwards        Pages: 150

The Global Biosimilars Partnering Terms and Agreements 2010 to 2023 report provides comprehensive understanding and unprecedented access to the biosimilars partnering deals and agreements entered into by the worlds leading healthcare companies......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs